Human protein c polypeptide
CA 2330171 A1 · Owner: Eli Lilly And Company · Inventors: Riggin, Ralph Meridith; Huang, Lihua
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An isolated human protein C polypeptide with a truncated heavy chain is described. This isolated polypeptide retains the biological activity of the wild-type human protein C. This polypeptide will be useful in the treatment of vascular occlusive disorders, hypercoagulable states thrombotic disorders and , disease states predisposing to thrombosis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 1, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 1, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 1, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.